Jazz Other Current Assets vs Short Term Investments Analysis

JAZZ Stock  USD 123.04  0.56  0.45%   
Jazz Pharmaceuticals financial indicator trend analysis is infinitely more than just investigating Jazz Pharmaceuticals PLC recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Jazz Pharmaceuticals PLC is a good investment. Please check the relationship between Jazz Pharmaceuticals Other Current Assets and its Short Term Investments accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jazz Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Other Current Assets vs Short Term Investments

Other Current Assets vs Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Jazz Pharmaceuticals PLC Other Current Assets account and Short Term Investments. At this time, the significance of the direction appears to have no relationship.
The correlation between Jazz Pharmaceuticals' Other Current Assets and Short Term Investments is 0.06. Overlapping area represents the amount of variation of Other Current Assets that can explain the historical movement of Short Term Investments in the same time period over historical financial statements of Jazz Pharmaceuticals PLC, assuming nothing else is changed. The correlation between historical values of Jazz Pharmaceuticals' Other Current Assets and Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Assets of Jazz Pharmaceuticals PLC are associated (or correlated) with its Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Investments has no effect on the direction of Other Current Assets i.e., Jazz Pharmaceuticals' Other Current Assets and Short Term Investments go up and down completely randomly.

Correlation Coefficient

0.06
Relationship DirectionPositive 
Relationship StrengthInsignificant

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.

Short Term Investments

Short Term Investments is an item under the current assets section of Jazz Pharmaceuticals balance sheet. It contains any investments Jazz Pharmaceuticals PLC undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Jazz Pharmaceuticals PLC can easily liquidate in the marketplace.
Most indicators from Jazz Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Jazz Pharmaceuticals PLC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jazz Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
At this time, Jazz Pharmaceuticals' Selling General Administrative is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 0.39 in 2024, despite the fact that Tax Provision is likely to grow to (177.5 M).
 2021 2022 2023 2024 (projected)
Gross Profit2.7B3.1B3.4B3.6B
Total Revenue3.1B3.7B3.8B4.0B

Jazz Pharmaceuticals fundamental ratios Correlations

0.430.340.380.320.530.360.410.30.40.350.460.420.270.320.350.40.410.490.070.360.220.260.530.360.36
0.430.980.970.90.910.940.790.960.750.960.710.990.870.650.980.610.980.990.110.980.890.940.980.980.95
0.340.980.980.910.810.950.70.990.610.970.690.970.850.591.00.510.960.96-0.040.990.940.960.941.00.9
0.380.970.980.940.830.90.690.950.640.980.760.950.890.610.970.60.980.960.020.960.890.970.950.980.9
0.320.90.910.940.790.830.540.850.610.920.860.850.880.450.870.710.950.880.090.860.770.980.90.90.87
0.530.910.810.830.790.80.860.780.930.810.690.880.80.690.80.760.890.910.440.80.680.790.950.820.95
0.360.940.950.90.830.80.70.960.650.920.570.970.80.440.950.40.890.94-0.090.960.890.870.890.960.87
0.410.790.70.690.540.860.70.730.860.680.390.790.680.820.720.510.740.780.430.730.660.610.80.710.85
0.30.960.990.950.850.780.960.730.590.960.570.980.80.590.990.40.920.95-0.080.990.960.910.90.990.87
0.40.750.610.640.610.930.650.860.590.610.540.720.710.610.610.720.740.760.60.610.440.60.80.630.87
0.350.960.970.980.920.810.920.680.960.610.710.950.90.550.970.520.960.95-0.060.960.920.950.930.980.9
0.460.710.690.760.860.690.570.390.570.540.710.630.750.460.650.870.810.720.170.630.50.780.780.680.7
0.420.990.970.950.850.880.970.790.980.720.950.630.830.610.980.50.950.990.030.980.910.90.960.980.92
0.270.870.850.890.880.80.80.680.80.710.90.750.830.510.830.650.920.860.150.820.70.850.870.850.91
0.320.650.590.610.450.690.440.820.590.610.550.460.610.510.610.560.640.620.420.610.60.530.680.590.66
0.350.981.00.970.870.80.950.720.990.610.970.650.980.830.610.470.950.96-0.071.00.950.930.931.00.88
0.40.610.510.60.710.760.40.510.40.720.520.870.50.650.560.470.70.590.640.450.30.640.710.50.71
0.410.980.960.980.950.890.890.740.920.740.960.810.950.920.640.950.70.970.140.940.830.950.980.960.95
0.490.990.960.960.880.910.940.780.950.760.950.720.990.860.620.960.590.970.080.970.860.910.980.970.94
0.070.11-0.040.020.090.44-0.090.43-0.080.6-0.060.170.030.150.42-0.070.640.140.08-0.08-0.180.060.21-0.050.33
0.360.980.990.960.860.80.960.730.990.610.960.630.980.820.611.00.450.940.97-0.080.950.920.931.00.88
0.220.890.940.890.770.680.890.660.960.440.920.50.910.70.60.950.30.830.86-0.180.950.870.820.940.77
0.260.940.960.970.980.790.870.610.910.60.950.780.90.850.530.930.640.950.910.060.920.870.910.950.89
0.530.980.940.950.90.950.890.80.90.80.930.780.960.870.680.930.710.980.980.210.930.820.910.940.96
0.360.981.00.980.90.820.960.710.990.630.980.680.980.850.591.00.50.960.97-0.051.00.940.950.940.9
0.360.950.90.90.870.950.870.850.870.870.90.70.920.910.660.880.710.950.940.330.880.770.890.960.9
Click cells to compare fundamentals

Jazz Pharmaceuticals Account Relationship Matchups

Jazz Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Common Stock Shares Outstanding57.6M56.5M59.7M62.5M72.1M51.5M
Total Assets5.5B6.5B12.3B10.8B11.4B12.0B
Short Long Term Debt Total1.8B2.2B6.1B5.8B5.8B6.1B
Other Current Liab278.8M338.3M650.5M787.3M774.5M813.2M
Total Current Liabilities364.5M653.7M809.3M933.2M1.5B1.6B
Total Stockholder Equity3.1B3.7B4.0B3.1B3.7B3.9B
Other Liab337.7M233.9M1.4B1.0B1.2B1.3B
Property Plant And Equipment Net270.9M257.1M343.4M301.4M235.0M119.6M
Net Debt1.1B1.2B5.5B4.9B4.3B4.5B
Retained Earnings1.1B1.2B830.2M733.6M878.7M922.6M
Accounts Payable47.5M26.9M100.3M90.8M102.8M107.9M
Cash637.3M1.1B591.4M881.5M1.5B1.6B
Non Current Assets Total3.9B3.7B9.7B8.2B8.0B8.4B
Non Currrent Assets Other47.9M25.7M40.8M58.9M69.2M72.7M
Other Assets272.2M415.0M363.9M435.1M171.5M136.8M
Long Term Debt1.6B1.8B6.0B5.7B5.1B5.4B
Cash And Short Term Investments1.1B2.1B591.4M881.5M1.6B1.7B
Net Receivables356.0M396.5M563.4M651.5M705.8M741.1M
Good Will920.0M958.3M1.8B1.7B1.8B1.8B
Short Term Investments515M440M1.1B30M120M147.5M
Liabilities And Stockholders Equity5.5B6.5B12.3B10.8B11.4B12.0B
Non Current Liabilities Total2.1B2.2B7.5B6.8B6.1B6.4B
Inventory78.6M95.4M1.1B714.1M597.0M626.9M
Other Current Assets78.9M214.9M383.8M359.1M506.3M531.6M
Other Stockholder Equity2.3B2.6B3.5B3.5B3.7B3.9B
Total Liab2.4B2.9B8.3B7.7B7.7B8.0B
Property Plant And Equipment Gross270.9M257.1M343.4M301.4M368.3M386.8M
Total Current Assets1.6B2.8B2.6B2.6B3.4B3.6B
Accumulated Other Comprehensive Income(223.4M)(134.4M)(400.4M)(1.1B)(842.1M)(800.0M)
Intangible Assets2.4B2.2B7.2B5.8B5.4B5.7B
Property Plant Equipment270.9M127.9M343.4M301.4M346.6M363.9M
Current Deferred Revenue4.7M2.5M2.1M463K116.1M121.9M
Net Tangible Assets(250.0M)648.7M(5.0B)(4.3B)(3.9B)(3.7B)
Capital Surpluse2.3B2.6B3.5B3.5B4.0B2.2B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Jazz Stock Analysis

When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.